Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sevoflurane Postconditioning in Moyamoya Disease Revascularization
NCT02510586Unknown
- Sponsor
- Seoul National University Hospital
- Start
- Aug 2015
- Primary completion
- Aug 2018
- Modality
- Small Molecules
01
Overview
Randomised, double-blind trial of sevoflurane in cerebral hyperperfusion syndrome (CHS), sponsored by Seoul National University Hospital. Primary endpoint: Incidence of postoperative cerebral hyperperfusion syndrome at 15 days. Status: unknown.
02
Drugs
sevoflurane
03
Conditions
cerebral hyperperfusion syndrome (CHS)
Beyond the preview
Go deeper on NCT02510586.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02510586.